Amphiregulin is a potent mitogen in human pancreatic cancer cells: Correlation with patient survival

M. Yokoyama, M. Ebert, H. Funatomi, H. Friess, M. W. Buchler, G. R. Johnson, Murray Korc

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

The epidermal growth factor (EGF) receptor (EGFR) is activated by EGF and other EGF-like growth factors, including amphiregulin (AR). We characterized the localization and mitogenic action of AR in T3M4 and COLO-357 human pancreatic cancer cell lines and determined whether the presence of AR in human pancreatic cancers correlates with patient survival. Both T3M4 and COLO-357 cells were found to be extremely sensitive to AR, one-half maximal stimulation occurring at a concentration of 70 and 50 pM, respectively. The magnitude of the stimulatory effect was greater with AR than with EGF. Both cell lines exhibited AR immunostaining, which was present in a variable manner in the cytoplasm, nucleus and nucleoli. Immunohistochemical analysis of 62 pancreatic cancer tissues revealed the presence of nuclear and/or cytoplasmic AR immunoreactivity in the cancer cells. Cytoplasmic, but not nuclear localization of AR in the pancreatic cancer cells was associated with a statistically significant decrease in the post-operative survival period. The presence of EGFR alone in the cancer cells did not correlate with decreased survival, whereas coexpression of cytoplasmic AR and EGFR was associated with shorter survival. Distant metastases did not always exhibit cytoplasmic AR immunoreactivity. These findings point to the existence of an EGFR: AR autocrine loop in human pancreatic cancer which may contribute to its biological aggressiveness.

Original languageEnglish (US)
Pages (from-to)625-631
Number of pages7
JournalInternational Journal of Oncology
Volume6
Issue number3
StatePublished - 1995
Externally publishedYes

Fingerprint

Pancreatic Neoplasms
Mitogens
Survival
Epidermal Growth Factor Receptor
Epidermal Growth Factor
Amphiregulin
Cell Line
Neoplasms
Intercellular Signaling Peptides and Proteins
Cytoplasm
Neoplasm Metastasis

Keywords

  • amphiregulin
  • EGF receptor
  • human pancreatic cancer

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Yokoyama, M., Ebert, M., Funatomi, H., Friess, H., Buchler, M. W., Johnson, G. R., & Korc, M. (1995). Amphiregulin is a potent mitogen in human pancreatic cancer cells: Correlation with patient survival. International Journal of Oncology, 6(3), 625-631.

Amphiregulin is a potent mitogen in human pancreatic cancer cells : Correlation with patient survival. / Yokoyama, M.; Ebert, M.; Funatomi, H.; Friess, H.; Buchler, M. W.; Johnson, G. R.; Korc, Murray.

In: International Journal of Oncology, Vol. 6, No. 3, 1995, p. 625-631.

Research output: Contribution to journalArticle

Yokoyama, M, Ebert, M, Funatomi, H, Friess, H, Buchler, MW, Johnson, GR & Korc, M 1995, 'Amphiregulin is a potent mitogen in human pancreatic cancer cells: Correlation with patient survival', International Journal of Oncology, vol. 6, no. 3, pp. 625-631.
Yokoyama M, Ebert M, Funatomi H, Friess H, Buchler MW, Johnson GR et al. Amphiregulin is a potent mitogen in human pancreatic cancer cells: Correlation with patient survival. International Journal of Oncology. 1995;6(3):625-631.
Yokoyama, M. ; Ebert, M. ; Funatomi, H. ; Friess, H. ; Buchler, M. W. ; Johnson, G. R. ; Korc, Murray. / Amphiregulin is a potent mitogen in human pancreatic cancer cells : Correlation with patient survival. In: International Journal of Oncology. 1995 ; Vol. 6, No. 3. pp. 625-631.
@article{72ddcbbafe414eeaa7ccf558df29ef94,
title = "Amphiregulin is a potent mitogen in human pancreatic cancer cells: Correlation with patient survival",
abstract = "The epidermal growth factor (EGF) receptor (EGFR) is activated by EGF and other EGF-like growth factors, including amphiregulin (AR). We characterized the localization and mitogenic action of AR in T3M4 and COLO-357 human pancreatic cancer cell lines and determined whether the presence of AR in human pancreatic cancers correlates with patient survival. Both T3M4 and COLO-357 cells were found to be extremely sensitive to AR, one-half maximal stimulation occurring at a concentration of 70 and 50 pM, respectively. The magnitude of the stimulatory effect was greater with AR than with EGF. Both cell lines exhibited AR immunostaining, which was present in a variable manner in the cytoplasm, nucleus and nucleoli. Immunohistochemical analysis of 62 pancreatic cancer tissues revealed the presence of nuclear and/or cytoplasmic AR immunoreactivity in the cancer cells. Cytoplasmic, but not nuclear localization of AR in the pancreatic cancer cells was associated with a statistically significant decrease in the post-operative survival period. The presence of EGFR alone in the cancer cells did not correlate with decreased survival, whereas coexpression of cytoplasmic AR and EGFR was associated with shorter survival. Distant metastases did not always exhibit cytoplasmic AR immunoreactivity. These findings point to the existence of an EGFR: AR autocrine loop in human pancreatic cancer which may contribute to its biological aggressiveness.",
keywords = "amphiregulin, EGF receptor, human pancreatic cancer",
author = "M. Yokoyama and M. Ebert and H. Funatomi and H. Friess and Buchler, {M. W.} and Johnson, {G. R.} and Murray Korc",
year = "1995",
language = "English (US)",
volume = "6",
pages = "625--631",
journal = "International Journal of Oncology",
issn = "1019-6439",
publisher = "Spandidos Publications",
number = "3",

}

TY - JOUR

T1 - Amphiregulin is a potent mitogen in human pancreatic cancer cells

T2 - Correlation with patient survival

AU - Yokoyama, M.

AU - Ebert, M.

AU - Funatomi, H.

AU - Friess, H.

AU - Buchler, M. W.

AU - Johnson, G. R.

AU - Korc, Murray

PY - 1995

Y1 - 1995

N2 - The epidermal growth factor (EGF) receptor (EGFR) is activated by EGF and other EGF-like growth factors, including amphiregulin (AR). We characterized the localization and mitogenic action of AR in T3M4 and COLO-357 human pancreatic cancer cell lines and determined whether the presence of AR in human pancreatic cancers correlates with patient survival. Both T3M4 and COLO-357 cells were found to be extremely sensitive to AR, one-half maximal stimulation occurring at a concentration of 70 and 50 pM, respectively. The magnitude of the stimulatory effect was greater with AR than with EGF. Both cell lines exhibited AR immunostaining, which was present in a variable manner in the cytoplasm, nucleus and nucleoli. Immunohistochemical analysis of 62 pancreatic cancer tissues revealed the presence of nuclear and/or cytoplasmic AR immunoreactivity in the cancer cells. Cytoplasmic, but not nuclear localization of AR in the pancreatic cancer cells was associated with a statistically significant decrease in the post-operative survival period. The presence of EGFR alone in the cancer cells did not correlate with decreased survival, whereas coexpression of cytoplasmic AR and EGFR was associated with shorter survival. Distant metastases did not always exhibit cytoplasmic AR immunoreactivity. These findings point to the existence of an EGFR: AR autocrine loop in human pancreatic cancer which may contribute to its biological aggressiveness.

AB - The epidermal growth factor (EGF) receptor (EGFR) is activated by EGF and other EGF-like growth factors, including amphiregulin (AR). We characterized the localization and mitogenic action of AR in T3M4 and COLO-357 human pancreatic cancer cell lines and determined whether the presence of AR in human pancreatic cancers correlates with patient survival. Both T3M4 and COLO-357 cells were found to be extremely sensitive to AR, one-half maximal stimulation occurring at a concentration of 70 and 50 pM, respectively. The magnitude of the stimulatory effect was greater with AR than with EGF. Both cell lines exhibited AR immunostaining, which was present in a variable manner in the cytoplasm, nucleus and nucleoli. Immunohistochemical analysis of 62 pancreatic cancer tissues revealed the presence of nuclear and/or cytoplasmic AR immunoreactivity in the cancer cells. Cytoplasmic, but not nuclear localization of AR in the pancreatic cancer cells was associated with a statistically significant decrease in the post-operative survival period. The presence of EGFR alone in the cancer cells did not correlate with decreased survival, whereas coexpression of cytoplasmic AR and EGFR was associated with shorter survival. Distant metastases did not always exhibit cytoplasmic AR immunoreactivity. These findings point to the existence of an EGFR: AR autocrine loop in human pancreatic cancer which may contribute to its biological aggressiveness.

KW - amphiregulin

KW - EGF receptor

KW - human pancreatic cancer

UR - http://www.scopus.com/inward/record.url?scp=0028918095&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028918095&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0028918095

VL - 6

SP - 625

EP - 631

JO - International Journal of Oncology

JF - International Journal of Oncology

SN - 1019-6439

IS - 3

ER -